Björnsson E, Sørensen M, Lefèvre J P. "一种多巴酚丁胺杂质35的合成方法" [P]. European Patent, EP 3069416 A1, 2020-04-05.
发明人罗永刚,韩伟,黄志刚. "Method for the Synthesis of Dobutamine Impurity 35" [P]. 中国发明专利, 专利号 CN 110824858 B, 授权公告日 2023-09-24.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of 多巴酚丁胺杂质35 in Pharmaceutical Formulations". Sci. Total Environ., 2024, 2188, (3), 7614-7618.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 多巴酚丁胺杂质35 as an Impurity". Biomed. Chromatogr., 2015, 1061, (7), 3302-3312.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Dobutamine Impurity 35 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2021, 1011, (2), 9544-9555.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 多巴酚丁胺杂质35 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2023, 1085, 9036-9064.